{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:24:05Z","timestamp":1788917045955,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.vaccine.2023.11.050","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T15:53:54Z","timestamp":1701446034000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and immunogenicity of locally produced trivalent inactivated influenza vaccine (Tri Fluvac) in healthy Thai adults aged 18\u201364\u00a0years in Nakhon Phanom: A Phase III double blinded, three-arm, randomized, controlled trial"],"prefix":"10.1016","volume":"42","author":[{"given":"Kriengkrai","family":"Prasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-2731","authenticated-orcid":false,"given":"Prabda","family":"Praphasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatairat","family":"Lerdsamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutthichai","family":"Nakphook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darunee","family":"Ditsungnoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutthinan","family":"Chawalchitiporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanlaya","family":"Sornwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittisak","family":"Poopipatpol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponthip","family":"Wirachwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piengthong","family":"Narakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchaiya","family":"Surichan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nava","family":"Suthepakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napawan","family":"Thangsupanimitchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakrarat","family":"Pittayawonganon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilaipan","family":"Puthavathana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja J.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanton","family":"Patumanond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2023.11.050_b0005","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.vaccine.2011.02.079","article-title":"WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer","volume":"29","author":"Friede","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2023.11.050_b0010","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1016\/j.vaccine.2011.04.120","article-title":"Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic","volume":"29","author":"Surichan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.050_b0015","unstructured":"FDA. Non-Inferiority Clinical Trials to Establish Effectiveness: Guidance for Industry. Available at: https:\/\/www.fda.gov\/media\/78504\/download [accessed April 14]."},{"key":"10.1016\/j.vaccine.2023.11.050_b0020","unstructured":"FDA. Guidance for Industry: Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines. Available at: https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Guidance-for-Industry--Clinical-Data-Needed-to-Support-the-Licensure-of-Seasonal-Inactivated-Influenza-Vaccines.pdf [accessed April 13]."},{"key":"10.1016\/j.vaccine.2023.11.050_b0025","unstructured":"WHO. WHO surveillance case definitions for ILI and SARI. Available at: https:\/\/www.who.int\/teams\/global-influenza-programme\/surveillance-and-monitoring\/case-definitions-for-ili-and-sari#:\u223c:text=SARI%20case%20definition,within%20the%20last%2010%20days."},{"key":"10.1016\/j.vaccine.2023.11.050_b0030","unstructured":"WHO. WHO information forthe molecular detection of influenza viruses. Available at: https:\/\/cdn.who.int\/media\/docs\/default-source\/influenza\/molecular-detention-of-influenza-viruses\/protocols_influenza_virus_detection_feb_2021.pdf?sfvrsn=df7d268a_5 [accessed April 10]."},{"key":"10.1016\/j.vaccine.2023.11.050_b0035","unstructured":"WHO. WHO manual on animal influenza diagnosis and surveillance. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/68026\/WHO_CDS_CSR_NCS_2002.5.pdf?sequence=1&isAllowed=y [accessed April 10]."},{"key":"10.1016\/j.vaccine.2023.11.050_b0040","unstructured":"FDA. Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/toxicity-grading-scale-healthy-adult-and-adolescent-volunteers-enrolled-preventive-vaccine-clinical."},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.050_b0045","doi-asserted-by":"crossref","first-page":"e26239","DOI":"10.1371\/journal.pone.0026239","article-title":"Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis","volume":"6","author":"Kuster","year":"2011","journal-title":"PLoS One"},{"issue":"7048","key":"10.1016\/j.vaccine.2023.11.050_b0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/bmj.313.7048.36","article-title":"Trials to assess equivalence: the importance of rigorous methods","volume":"313","author":"Jones","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.11.050_b0055","series-title":"Field Trials of Health Interventions: A Toolbox","author":"Smith","year":"2015"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.050_b0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/20477724.2020.1777803","article-title":"Impact of COVID-19 public health interventions on influenza incidence in Thailand","volume":"114","author":"Suntronwong","year":"2020","journal-title":"Pathog Glob Health"},{"issue":"9767","key":"10.1016\/j.vaccine.2023.11.050_b0065","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(10)62228-3","article-title":"Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"377","author":"Barrett","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.050_b0070","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/21645515.2017.1384106","article-title":"Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial","volume":"14","author":"Sesay","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.050_b0075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/vim.2012.0024","article-title":"Kinetics of the antibody response to seasonal influenza vaccination among the elderly","volume":"25","author":"Kositanont","year":"2012","journal-title":"Viral Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.050_b0080","doi-asserted-by":"crossref","first-page":"2071061","DOI":"10.1080\/21645515.2022.2071061","article-title":"Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged >\/=60 years in Taizhou City, Zhejiang Province, China, during the 2018\u20132019 season","volume":"18","author":"Liao","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.050_b0085","doi-asserted-by":"crossref","first-page":"e0253028","DOI":"10.1371\/journal.pone.0253028","article-title":"Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study","volume":"16","author":"Nakphook","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.050_b0090","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1750-2659.2011.00302.x","article-title":"Influenza viruses in Thailand: 7 years of sentinel surveillance data, 2004\u20132010","volume":"6","author":"Chittaganpitch","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.050_b0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41182-022-00419-2","article-title":"Pneumonia, influenza, and dengue cases decreased after the COVID-19 pandemic in Thailand","volume":"50","author":"Prasertbun","year":"2022","journal-title":"Trop Med Health"},{"key":"10.1016\/j.vaccine.2023.11.050_b0100","unstructured":"Center TNI. Report on changes in influenza strains. Available at: http:\/\/www.thainihnic.org\/influenza\/main.php [accessed April 13]."},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.050_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2020\u201321 influenza season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.050_b0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4161\/hv.22908","article-title":"Correlates of protection to influenza virus, where do we go from here?","volume":"9","author":"Cox","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2023.11.050_b0115","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2023.11.050_b0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0264-410X(94)90241-0","article-title":"Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial","volume":"12","author":"Govaert","year":"1994","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.050_b0125","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.050_b0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vaccine.2019.10.028","article-title":"Seasonal influenza vaccination in middle-income countries: Assessment of immunization practices in Belarus, Morocco, and Thailand","volume":"38","author":"Mantel","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.050_b0135","unstructured":"Control TDoD. Covid-19 Vaccination Progress Report for March 10, 2023. Available at: https:\/\/ddc.moph.go.th\/vaccine-covid19\/pages\/%E0%B8%A3%E0%B8%B2%E0%B8%A2%E0%B8%87%E0%B8%B2%E0%B8%99%E0%B8%84%E0%B8%A7%E0%B8%B2%E0%B8%A1%E0%B8%81%E0%B9%89%E0%B8%B2%E0%B8%A7%E0%B8%AB%E0%B8%99%E0%B9%89%E0%B8%B2%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B9%83%E0%B8%AB%E0%B9%89%E0%B8%9A%E0%B8%A3%E0%B8%B4%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B8%89%E0%B8%B5%E0%B8%94%E0%B8%A7%E0%B8%B1%E0%B8%84%E0%B8%8B%E0%B8%B5%E0%B8%99%E0%B9%82%E0%B8%84%E0%B8%A7%E0%B8%B4%E0%B8%94-19 [accessed April 10]."},{"key":"10.1016\/j.vaccine.2023.11.050_b0140","unstructured":"Health MoP. MOPH Immunization Center. Available at: https:\/\/mohpromt.moph.go.th\/mpc\/mp-pf\/mophic\/ [accessed June 5]."},{"issue":"19","key":"10.1016\/j.vaccine.2023.11.050_b0145","first-page":"185","article-title":"Vaccines against influenza: WHO position paper \u2013 May 2022","volume":"97","author":"WHO","year":"2022","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:32Z","timestamp":1759404752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23013968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0264410X23013968"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of locally produced trivalent inactivated influenza vaccine (Tri Fluvac) in healthy Thai adults aged 18\u201364\u00a0years in Nakhon Phanom: A Phase III double blinded, three-arm, randomized, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}